These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


202 related items for PubMed ID: 27649298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. AMPK Serves as a Therapeutic Target Against Anemia of Inflammation.
    Wang M, Xin H, Tang W, Li Y, Zhang Z, Fan L, Miao L, Tan B, Wang X, Zhu YZ.
    Antioxid Redox Signal; 2017 Aug 10; 27(5):251-268. PubMed ID: 27923278
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.
    Wu J, Guo W, Lin SZ, Wang ZJ, Kan JT, Chen SY, Zhu YZ.
    Cell Death Dis; 2016 Aug 18; 7(8):e2339. PubMed ID: 27537522
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. S-Propargyl-cysteine (SPRC) attenuated lipopolysaccharide-induced inflammatory response in H9c2 cells involved in a hydrogen sulfide-dependent mechanism.
    Pan LL, Liu XH, Gong QH, Zhu YZ.
    Amino Acids; 2011 Jun 18; 41(1):205-15. PubMed ID: 21308383
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardioprotective effects and pharmacokinetic properties of a controlled release formulation of a novel hydrogen sulfide donor in rats with acute myocardial infarction.
    Tran BH, Huang C, Zhang Q, Liu X, Lin S, Liu H, Wang S, Zhu YZ.
    Biosci Rep; 2015 Apr 30; 35(3):. PubMed ID: 26182378
    [Abstract] [Full Text] [Related]

  • 13. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage.
    Wang XH, Wang F, You SJ, Cao YJ, Cao LD, Han Q, Liu CF, Hu LF.
    Cell Signal; 2013 Nov 30; 25(11):2255-62. PubMed ID: 23872072
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway.
    Wang Q, Liu HR, Mu Q, Rose P, Zhu YZ.
    J Cardiovasc Pharmacol; 2009 Aug 30; 54(2):139-46. PubMed ID: 19546814
    [Abstract] [Full Text] [Related]

  • 18. Novel Liposome Eencapsulated Guanosine Di Phosphate based Therapeutic Target against Anemia of Inflammation.
    Angmo S, Rana S, Yadav K, Sandhir R, Singhal NK.
    Sci Rep; 2018 Dec 06; 8(1):17684. PubMed ID: 30523271
    [Abstract] [Full Text] [Related]

  • 19. Novel hydrogen sulfide-releasing compound, S-propargyl-cysteine, prevents STZ-induced diabetic nephropathy.
    Qian X, Li X, Ma F, Luo S, Ge R, Zhu Y.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):931-938. PubMed ID: 27055593
    [Abstract] [Full Text] [Related]

  • 20. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways.
    Shin DY, Chung J, Joe Y, Pae HO, Chang KC, Cho GJ, Ryter SW, Chung HT.
    Blood; 2012 Mar 15; 119(11):2523-32. PubMed ID: 22262759
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.